Red Light Holland Psilocybin Microdosing Capsules Pass 8 Weeks Of Stability Testing
Portfolio Pulse from Vuk Zdinjak
Red Light Holland Corp. (OTCQB:TRUFF) (CSE:TRIP) has announced that its psilocybin microdosing capsules have passed 8 weeks of stability testing. The tests were conducted by CCrest Laboratories Inc., a Montreal-based pharmaceutical laboratory. The capsules are intended to be distributed in Australasia by NUBU Pharmaceuticals. A full stability report is expected after 3 months of testing.
August 22, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Red Light Holland's psilocybin microdosing capsules have passed 8 weeks of stability testing, which is a positive development for the company.
The successful stability testing of Red Light Holland's psilocybin microdosing capsules is a positive development for the company. This could potentially lead to increased sales and revenue, which would be beneficial for the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Red Light Holland's psilocybin microdosing capsules have passed 8 weeks of stability testing, which is a positive development for the company.
The successful stability testing of Red Light Holland's psilocybin microdosing capsules is a positive development for the company. This could potentially lead to increased sales and revenue, which would be beneficial for the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100